TerSera Therapeutics LLC initiated a recall of Zoladex (goserelin) on August 31, 2026. The FDA has classified this action as a Class II recall. The recall affects the Zoladex 3.6 mg implant, supplied as a single-use syringe in a carton, NDC 70720-950-36, Rx only. The product is manufactured for TerSera Therapeutics LLC of Deerfield, Illinois, by AstraZeneca UK Limited in Macclesfield, England, and is listed as a product of Switzerland.
The stated reason for the recall is temperature abuse. According to the recall record, affected product sat in a non-temperature-controlled FedEx trailer under ambient outdoor conditions for 25.5 hours. The recall status is listed as ongoing as of the identified date.
This recall identifier is D-0875-2026. The classification, reason, firm, and status described here reflect the information provided in the recall record and do not indicate confirmed harm or adverse outcomes associated with the affected product. Readers seeking further detail on this specific action should consult the FDA recall listing directly.
For general background on this compound, see the linked compound overview.